SF Healthcare Week: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year
BiotechTV - News
00:00
Addressing theoretical cardiac concerns
Marc addresses literature references, an FDA-requested sub-study, and finds no cardiac issues to date.
Play episode from 06:18
Transcript
